188 related articles for article (PubMed ID: 33086288)
1. Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain.
Beckley JT; Pajouhesh H; Luu G; Klas S; Delwig A; Monteleone D; Zhou X; Giuvelis D; Meng ID; Yeomans DC; Hunter JC; Mulcahy JV
Pain; 2021 Apr; 162(4):1250-1261. PubMed ID: 33086288
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a selective, state-independent inhibitor of Na
Pajouhesh H; Beckley JT; Delwig A; Hajare HS; Luu G; Monteleone D; Zhou X; Ligutti J; Amagasu S; Moyer BD; Yeomans DC; Du Bois J; Mulcahy JV
Sci Rep; 2020 Sep; 10(1):14791. PubMed ID: 32908170
[TBL] [Abstract][Full Text] [Related]
3. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
[TBL] [Abstract][Full Text] [Related]
4. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
Xue Y; Chidiac C; Herault Y; Gaveriaux-Ruff C
Neurosci Lett; 2021 May; 753():135844. PubMed ID: 33775738
[TBL] [Abstract][Full Text] [Related]
5. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels.
Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R
ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467
[TBL] [Abstract][Full Text] [Related]
6.
Zhang F; Zhang C; Xu X; Zhang Y; Gong X; Yang Z; Zhang H; Tang D; Liang S; Liu Z
J Biol Chem; 2019 May; 294(18):7324-7334. PubMed ID: 30804211
[TBL] [Abstract][Full Text] [Related]
7. Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models.
Urru M; Muzzi M; Coppi E; Ranieri G; Buonvicino D; Camaioni E; Coppini R; Pugliese AM; Tanaka B; Estacion M; Waxman SG; Dib-Hajj SD; Chiarugi A
Pain; 2020 Apr; 161(4):831-841. PubMed ID: 31815915
[TBL] [Abstract][Full Text] [Related]
8. [Pain and analgesia : Mutations of voltage-gated sodium channels].
Eberhardt MJ; Leffler A
Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
[TBL] [Abstract][Full Text] [Related]
9. Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.
Kamei T; Kudo T; Yamane H; Ishibashi F; Takada Y; Honda S; Maezawa Y; Ikeda K; Oyamada Y
Biochem Biophys Res Commun; 2024 Aug; 721():150126. PubMed ID: 38776832
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Spider (
Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel Na
Gilchrist JM; Yang ND; Jiang V; Moyer BD
Mol Pharmacol; 2024 Feb; 105(3):233-249. PubMed ID: 38195157
[TBL] [Abstract][Full Text] [Related]
12. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
[TBL] [Abstract][Full Text] [Related]
13. Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat.
Rahman W; Dickenson AH
Neuroscience; 2015 Jun; 295():103-16. PubMed ID: 25818052
[TBL] [Abstract][Full Text] [Related]
14. New aryl and acylsulfonamides as state-dependent inhibitors of Na
Zidar N; Tomašič T; Kikelj D; Durcik M; Tytgat J; Peigneur S; Rogers M; Haworth A; Kirby RW
Eur J Med Chem; 2023 Oct; 258():115530. PubMed ID: 37329714
[TBL] [Abstract][Full Text] [Related]
15. Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
Mulcahy JV; Pajouhesh H; Beckley JT; Delwig A; Du Bois J; Hunter JC
J Med Chem; 2019 Oct; 62(19):8695-8710. PubMed ID: 31012583
[TBL] [Abstract][Full Text] [Related]
16. Visceral and somatic pain modalities reveal Na
Hockley JR; González-Cano R; McMurray S; Tejada-Giraldez MA; McGuire C; Torres A; Wilbrey AL; Cibert-Goton V; Nieto FR; Pitcher T; Knowles CH; Baeyens JM; Wood JN; Winchester WJ; Bulmer DC; Cendán CM; McMurray G
J Physiol; 2017 Apr; 595(8):2661-2679. PubMed ID: 28105664
[TBL] [Abstract][Full Text] [Related]
17. No gain, no pain: NaV1.7 as an analgesic target.
King GF; Vetter I
ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Thériault O; Poulin H; Beaulieu JM; Chahine M
Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na
Kornecook TJ; Yin R; Altmann S; Be X; Berry V; Ilch CP; Jarosh M; Johnson D; Lee JH; Lehto SG; Ligutti J; Liu D; Luther J; Matson D; Ortuno D; Roberts J; Taborn K; Wang J; Weiss MM; Yu V; Zhu DXD; Fremeau RT; Moyer BD
J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457
[TBL] [Abstract][Full Text] [Related]
20. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
